Free delivery for all orders!
Based on studies demonstrating NMN’s ability to boost NAD+, Elevant uses a uniquely synthesized form of NMN, called NMN-C®. Ultra-pure, highly stable, and shown to have higher tolerability than other molecules promoted as NAD+ boosters, NMN-C® brings pharmaceutical-grade quality and unmatched levels of scientific rigor and transparency to consumer cellular optimization solutions.
An OECD 408 toxicology study – the first of its kind to be undertaken on NMN –demonstrated NMN-C® has a NOAEL tolerance level 3x higher than NR and almost 7x higher than NAM.
Meaning: Your body absorbs NMN more safely than other NAD+ boosters.NMN-C® is Self-GRAS in accordance with stringent US FDA regulatory guidelines. We manufacture in cGMP-certified facilities in Europe. Every NMN-C® batch is tested for purity, and impurities.
Meaning: NMN-C® is the highest quality and purity NMN on the market.NMN-C® has pharmaceutical-grade certification enabling it to be used in human trials. With 11 clinical trials underway, NMN-C® clinical trials are the most extensive in-human NMN research program to date.
Meaning: NMN-C® is safe and intensively researched.
NMN-C® vs others
“There are several products on the market prepared to raise NAD levels, including nicotinamide riboside, or nicotinamide mononucleotide, NMN. What differentiates the NMN-C® used in Elevant is that it is fully synthetic. In contrast, other NMN products on the market actually use enzymatic products from bacteria for the last step of the synthesis. And so, this fully synthetic product is likely to be pure and more efficient at raising NAD levels”
Eric VERDINNMN-C® vs Others
The long-term clinical trials have shown that NMN-C® is exceptionally well-tolerated. The upper intake level for a 60kg individual was calculated to be higher for NMN than other NAD+ boosters on the market. “The toxicology study on NMN has demonstrated that high dose of short term and repeated oral administration is safe and did not promote any side effects.”
Dr. Alessia GROZIOThanks for subscribing!
This email has been registered!